WulsinLRMaddockRBeitmanB. Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries. International Journal of Psychiatry in Medicine1999;29:97–105 (this issue).
2.
SheikhJISwalesPJ. Treatment of panic disorder in older adults: A pilot study comparison of alprazalom, imipramine and placebo. International Journal of Psychiatry in Medicine1999;29:107–117 (this issue).
3.
QuitkinFMMcGrathPJRabkinJGStewartJWRossDCTricamoEFleissJMarkowitzJKleinDF. Different types of placebo response in patients receiving antidepressants. American Journal of Psychiatry1991;148:197–203.
4.
BallengerJCBurrowsGDDuPontRLLesserIMNoyesRPecknoldJCRifkinASwinsonRP. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I: Efficacy in short term treatment. Archives of General Psychiatry1988;45:413–424.
5.
BrownWA. The placebo response in depression—A modest proposal. Harvard Mental Health Letter. December, 1995.
6.
den BoerJA. Pharmacotherapy of panic disorder: Differential efficacy from a clinical viewpoint. Journal of Clinical Psychiatry1998;59(suppl 8):30–36.
7.
BrownWAJohnsonMRChenMG. Clinical features of depressed patients who do and do not improve with placebo. Psychiatric Research1992;41:203–214.
8.
BrownWA. Predictors of placebo response in depression. Psychopharmacology Bulletin1988;24:14–17.
9.
EvansFJ. Expectancy, therapeutic instructions, and the placebo response. In WhiteLTurskyBSchwartzGE, editors. Placebo: Theory, research and mechanisms. New York: The Guilford Press. 1985:215–228.